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PI3KA panel of inﬂuenza A viruses encoding mutant NS1 proteins was created in which a number of NS1
functions, including interactions with dsRNA, PI3K, CPSF30 and PKR, were inhibited. Surprisingly, given
previous reports that NS1 activates PI3K to prevent apoptosis, the mutant viruses rUd-Y89F and rUd-P164/
7A that fail to activate PI3K did not induce any more apoptosis than wild-type virus in MRC-5 and A549 cells,
even though these cells are highly sensitive to inducers of apoptosis. Induction of cell death by the
apoptogenic rUd-184-8(P) virus could not be prevented by serum-mediated activation of PI3K/Akt. Neither
infection of MRC-5 or A549 cells with wild-type virus nor constitutive expression of NS1 prevented cell death
caused by apoptosis inducers, suggesting that NS1 is not directly anti-apoptotic. Our data suggest that the
loss of a functionally intact NS1 protein promotes apoptosis, but this is not due to an inability to activate
PI3K.
© 2009 Elsevier Inc. All rights reserved.Introduction
Apoptosis is a tightly controlled process whereby cells activate
pathways leading to their self-destruction in response to a wide
range of stimuli, including virus infection. These death pathways
culminate in the engulfment of apoptotic cell fragments by
neighbouring and phagocytic cells, preventing leakage of cell
contents into the extracellular environment. One of the initial
studies into the effects of apoptosis on virus replication demon-
strated that apoptosis decreased multiplication of an insect virus
by approximately 50-fold (Clem and Miller, 1993). However,
subsequent studies have shown that certain animal viruses,
including HSV-1, VSV and poliovirus, can replicate considerably
in apoptotic cells and that apoptosis induction only slightly reduces
viral titres (Koyama et al., 1998). It has been suggested that
apoptosis may play a more predominant role in limiting in vivo
animal virus infections, as phagocytosis of inﬂuenza A virus-
infected, apoptotic cells completely abrogates virus multiplication
and release (Fujimoto et al., 2000; Nakanishi et al., 2008).
Therefore, the primary reason that many viruses block apoptosis
may be to prevent apoptotic cell clearance by macrophages), mjk3@st-andrews.ac.uk
mr@st-andrews.ac.uk
ll rights reserved.(Koyama et al., 2000), thereby increasing virus multiplication and
suppressing cell-mediated immunity.
Inﬂuenza A viruses are segmented, negative sense RNA viruses
within the family Orthomyxoviridae. Their genome consists of eight
segments of viral RNA (vRNA), which encode 11 known proteins
(reviewed in Palese and Shaw, 2007). Two of these proteins, PB1-F2
(encoded on vRNA segment two) and NS1 (encoded on segment
eight), are non-structural and have been implicated in the regulation
of apoptosis (Chanturiya et al., 2004; Chen et al., 2001; Ehrhardt et al.,
2007; Gibbs et al., 2003; Shin et al., 2007a). It has previously been
shown that inﬂuenza A virus infection can lead to the induction of
apoptosis in tissue culture cells (Fesq et al., 1994; Hinshaw et al., 1994;
Takizawa et al., 1993) and a number of virally encoded proteins (PB1-
F2, NA,M1,M2) have been reported to induce this process (Chen et al.,
2001; Morris et al., 1999; Morris, Smith, and Sweet, 2002; Schultz-
Cherry and Hinshaw, 1996). However, there is still some disparity in
the role of the inﬂuenza virus NS1 protein in apoptosis regulation, as it
has been implicated in both the induction (Lam et al., 2008; Morris,
Smith, and Sweet, 2002; Schultz-Cherry et al., 2001; Stasakova et al.,
2005) and prevention (Ehrhardt et al., 2007; Shin et al., 2007a;
Zhirnov and Klenk, 2007; Zhirnov et al., 2002) of apoptosis.
NS1 is a multifunctional protein which demonstrates interferon
(IFN) antagonistic properties, mediated by numerous protein:protein
and protein:RNA interactions (reviewed in Hale et al., 2008b). NS1 has
been reported to inhibit the action of two IFN-induced proteins,
dsRNA-dependent protein kinase R (PKR) and 2′-5′-oligoadenylate
synthetase (OAS). NS1 directly binds to and inhibits PKR (Li et al.,
2006; Min et al., 2007; Takizawa, Ohashi, and Nakanishi, 1996; Tan
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OAS/RNase L pathway (Chien et al., 2004; Min and Krug, 2006; Wang
et al., 1999). NS1 (apart from that of A/Puerto Rico/8/34 virus) also
limits IFN production by inhibiting cellular pre-mRNA processing
through its interaction with the 30 kDa subunit of cleavage and
polyadenylation speciﬁcity factor (CPSF30) (Kochs, Garcia-Sastre, and
Martinez-Sobrido, 2007; Nemeroff et al., 1998; Noah, Twu, and Krug,
2003), and inhibiting mRNA nuclear export (Fortes, Beloso, and Ortin,
1994; Qiu and Krug, 1994). NS1 also prevents IFN-β induction by
inhibiting the activation of the cytoplasmic pathogen sensor RIG-I
(Guo et al., 2007; Mibayashi et al., 2007; Opitz et al., 2007; Pichlmair
et al., 2006) by speciﬁcally interacting with TRIM25 (Gack et al.,
2009), thereby preventing RIG-I CARD ubiquitination, which is
required for IFN-β induction (Gack et al., 2008; Gack et al., 2007;
Oshiumi et al., 2009).
The NS1-mediated effects on apoptosismay be partially dependent
on IFN inhibition by NS1, since sensitisation of cells to apoptosis is a
major element of the IFN-induced antiviral state (reviewed in Barber,
2001). dsRNA, PKR and OAS/RNase L, in addition to mediating the IFN
response, have all been shown to play an important role in triggering
apoptosis following viral infection (Castelli et al., 1997; Takizawa,
Ohashi, and Nakanishi, 1996; Zhou et al., 1998). It therefore seems
likely that the interaction with, and subsequent inhibition of, these
factors by NS1 could lead to the down-regulation of inﬂuenza virus-
induced apoptosis.
NS1 may also regulate apoptosis independently of IFN. NS1
activates PI3K signalling by binding to the p85-β regulatory subunit
of PI3K (Hale et al., 2008a; Hale et al., 2006; Shin et al., 2007b). PI3K
and its downstream effector, Akt, are important regulators of cell
growth, proliferation and survival (reviewed in Manning and Cantley,
2007) and it has been reported that the activation of PI3K by NS1
activates anti-apoptotic pathways (Ehrhardt et al., 2007; Shin et al.,
2007a; Zhirnov and Klenk, 2007).Table 1
Amino acid mutations introduced into the NS1 protein of mutant viruses.
Virus Mutation Consequenc
rUd-Y89F Tyr89Phe Prevents th
rUd-P164/7A Pro164Ala
Pro167Ala
Prevents th
Has been re
induction o
rUd-P162/4/7A Pro162Ala
Pro164Ala
Pro167Ala
Prevents th
rUd-Δ99 Ser99stop C-terminall
rUd-R38A Arg38Ala Prevents th
inhibition o
rUd-123/4 Ile123Ala
Met124Ala
Prevents th
increased v
rUd-184-8(P) Gly184Arg
Leu185Phe
Glu186Pro
Trp187Arg
Asn188Tyr
Unknown
rUd-184-8(L) Gly184Arg
Leu185Phe
Glu186Leu
Trp187Arg
Asn188Tyr
Prevents th
rUd-103/106 Phe103Leu
Met106Ile
DestabilizesPrevious studies reporting the various functions of the inﬂuenza
A virus NS1 protein have used a number of different viral strains,
some of which differ in the NS1 amino acid sequence at key residues.
Using reverse genetics, we introduced a number of mutations into
the NS1 protein of the A/Udorn/72 (H3N2) virus to create a panel of
mutant viruses with a single genetic background in which various
functions of the NS1 protein, including interactions with dsRNA,
PKR, CPSF30 and PI3K, were inhibited. The mutant viruses were used
to determine whether any of these previously reported interactions
are involved in regulating apoptosis. Whilst several of the mutant
viruses induced more cell death than wt virus, viruses defective in
PI3K binding did not. This indicates that to limit the induction of
apoptosis, inﬂuenza A viruses require a fully functional NS1 protein;
however, in contrast to previous reports, this does not require the
activation of PI3K.
Results
The generation of recombinant viruses
Amino acid mutations were introduced into the NS1 protein of A/
Udorn/72 virus by reverse genetics. The NS1 protein is known to be an
IFN antagonist, therefore it was possible that mutations engineered
into NS1may restrict or inhibit this function. To ensure virus recovery,
MDCK cells expressing the V protein of PIV5 (which prevents the cells
from responding to IFN) were generated as previously described
(Andrejeva et al., 2002) and used for virus recovery. The mutations
introduced into NS1 and the functions inhibited by each are
summarised in Table 1. The relative position of each mutation within
NS1 is highlighted in Fig. 1. Three mutant viruses were created in
which previously reported mutations were introduced into NS1 with
the aim of preventing the interaction with the p85β subunit of PI3K:
(i) rUd-Y89F (Hale et al., 2006), (ii) rUd-P164/7A (Shin et al., 2007a)e of mutation Reference
e NS1–PI3K interaction Hale et al. (2006)
e NS1–PI3K interaction.
ported to lead to the
f apoptosis
Shin et al. (2007a)
e NS1-PI3K interaction Shin et al. (2007a)
y truncated protein f 98 amino acids No reference
e NS1–dsRNA interaction. Prevents the
f the 2′-5′OAS/RNase L pathway
Wang et al. (1999)
Min and Krug, 2006
e NS1-PKR interaction and leads to
RNA synthesis early in infection
Min et al. (2007)
No reference
e NS1–CPSF30 interaction Noah et al. (2003)
the NS1–CPSF30 interaction Twu et al. (2007)
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on a discrepancy in the NS1 sequence of the mutant virus reported by
Shin et al. (2007a). They reported that the sequence of the mutant
virus contained two proline–alanine mutations at residues 164 and
167, whereas the primer sequences they used to create the virus
contained an additional proline–alanine mutation at residue 162. As it
was unclear whether the mutant virus contained two or three
mutations, bothmutantswere created for this study. Interestingly, the
triple mutant, rUd-P162/4/7A, took longer to recover and sequencing
analysis of the plaque puriﬁed virus stock revealed that another
mutant, rUd-Δ99, had also recovered alongside the rUd-P162/4/7A
virus. rUd-Δ99 contained the nucleotide sequence encoding the
P162/4/7Amutation; however, it also contained a stop codon after 98
codons of the NS1 ORF, thereby creating a truncated NS1 protein of 98
amino acids. Presumably, as both the rUd-P162/4/7A and rUd-Δ99
viruses were attenuated in tissue culture (data not shown), they were
unable to out-compete each other leading to the production of a
mixed population. The mutations in the two mutant NS1 proteins
were stably maintained through multiple passages and both viruses
were used in subsequent experiments.
The design of the rUd-R38A mutant is based on previous reports
that the R38A mutation in NS1 prevents it binding to dsRNA (Wang
et al., 1999). This mutant is therefore unable to block the activation
of the 2′-5′OAS/RNase L pathway (Min and Krug, 2006). The rUd-
123/4 mutant was designed to prevent the binding of NS1 to PKR
(Min et al., 2007), leading to PKR activation.
Two mutant viruses were created in which the interaction of NS1
with CPSF30 is either prevented (rUd-184-8(L)) (Noah, Twu, and
Krug, 2003) or destabilised (rUd-103/106) (Twu et al., 2007).
Interestingly, sequencing analysis revealed that a third mutant,
rUd-184-8(P), was generated during the recovery of the rUd-184-8
(L) virus. The two viruses were separated by plaque puriﬁcation and
the mutations were stably maintained through multiple passages.
Both viruses were used in subsequent experiments.
The ability of the mutant viruses to activate PI3K
The panel of mutant viruses was used to infect A549 (human lung
epithelial) cells at an MOI of 5 and the cells were lysed at 12 or 24
h post-infection (p.i.). The cell lysates were analysed by SDS-PAGE
and immunoblotting to detect the inﬂuenza virus NS1 protein and
phosphorylation of the cellular protein Akt (pAkt), a downstream
target of, and hence marker for, PI3K activation. The inﬂuenza A virus
M1 protein was detected to ensure that cells were equally infectedFig. 1. Schematic diagram of the NS1 protein of recombinant mutant viruses. The NS1
protein of A/Udorn/72 virus is 237 amino acids (aa) in length. It is notionally divided
into a 73 aa N-terminal RNA binding domain and a 164 aa C-terminal effector domain.
The aamutations introduced into the recombinant A/Udorn/72 (rUd) viruses described
in Table 1 are shown. The NS1:cellular protein/RNA interaction affected by each
mutation is highlighted in the open boxes. The “stop sign” indicates the position of the
termination codon introduced into the NS1 protein of the rUd-Δ99 virus.
Fig. 2. Akt activation in mutant virus-infected cells. A549 cells were infected with the
panel of mutant inﬂuenza viruses at an MOI of 5, lysed in disruption buffer at (a) 12 or
(b) 24 h p.i. Proteins were separated by SDS-PAGE followed by immunoblotting for the
detection of pAkt, NS1, M1 and β-actin. (c) Analysis of the plaque phenotype of the rUd
wt, rUd-Y89F, rUd-P164/7A and rUd-P162/4/7A viruses. Viruses were plaqued in
MDCK cells, and plaques visualised by immunostaining.with all viruses and the detection of β-actin ensured equal sample
loading. Levels of pAkt at both 12 h p.i. (Fig. 2a) and 24 h p.i. (Fig.
2b) varied between the different mutant virus-infected cells. At both
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produced levels of pAkt similar to wt virus. However, pAkt was
undetectable in cells infected with the rUd-184-8(P) and rUd-Δ99
viruses, which may have resulted from the decreased levels of NS1
observed in these samples when compared to those of wt virus
(Figs. 2a, b). Although the NS1 protein encoded by the rUd-Δ99
virus was expected to be truncated, no NS1-speciﬁc species could be
detected in rUd-Δ99 virus-infected cells using three separate NS1-
speciﬁc antisera (data not shown). NS1 expression in rUd-184-8(P)
virus-infected cells in the presence of proteosome inhibitors or in
pulse-chase experiments suggested that this mutant NS1 protein
was not unstable (data not shown). However, a recent study sug-
gested that mutations introduced into the NS1 gene can signiﬁcantly
affect the level of NS1 translation due to the disruption of mRNA
secondary structure (Ilyinskii et al., 2009). The reported mutations
included the deletion of residues 184–188, those mutated in the NS1
protein of the rUd-184-8(P) virus, which may explain the decreased
level of NS1 observed in cells infected with this virus.
As PKR activation has previously been shown to promote
activation of the PI3K pathway (Kazemi et al., 2007), it was surprising
to observe that pAkt was reduced in rUd-123/4 virus-infected cells at
both 12 and 24 h p.i. Similarly, rUd-184-8(L) virus-infected cells
exhibited lower pAkt levels at both time points. The three viruses
designed to prevent the NS1:PI3K interaction, (rUd-Y89F, rUd-P164/
7A and rUd-P162/4/7A) produced differing results. At 24 h p.i., pAkt
was absent in cells infected with the three mutant viruses. However,
at 12 h p.i., the level of pAkt detected in rUd-P164/7A virus-infected
cells, although lower than for rUd wt, was signiﬁcantly higher than
that of the other two mutants. No pAkt was detectable in rUd-Y89F
virus-infected cells at 12 h p.i., with only a very small amount
detectable in rUd-P162/4/7A virus-infected cells. This suggests that at
early times p.i., NS1 containing the Y89F mutation is less able to
activate PI3K than that containing the P164A/P167A mutations
reported by Shin et al. (2007a).
The plaque formation of the rUd-Y89F, rUd-164/7A and rUd-
P162/4/7A viruses was analysed alongside rUdwt virus inMDCK cells
(Fig. 2c). As previously reported (Hale et al., 2006), the plaque size of
the rUd-Y89F virus was reduced when compared to wt virus.
However, the rUd-P164/7A virus, which was previously reported to
form small plaques (Shin et al., 2007a) produced wt-like plaques,
whichmay be due to the observed activation of PI3K by this particular
mutant at 12 h p.i. (Fig. 2a). The rUd-P162/4/7A virus, which
demonstrated low levels of pAkt at 12 h p.i., produced small plaques
similar to the rUd-Y89F virus. This suggests that the virus reported by
Shin et al. may contain the three proline–alanine mutations reported
in their primer sequences.
The effect of mutant NS1 proteins on apoptosis induction by inﬂuenza
virus
During the characterisation of these mutant viruses, it became
apparent that some viruses induced more cell death than others. To
quantify these differences, A549 cells were infected with the panel of
mutant viruses and cell viability was quantiﬁed by a colorimetric wst-
1-based assay at various times p.i. (Fig. 3a). Infection with all viruses
resulted in similar levels of cell viability up to 24 h p.i.; however, by
36 h p.i. the rUd-184-8(L), rUd-P162/4/7A, rUd-Δ99 and rUd-184-8
(P) viruses induced 12%, 14%, 26% and 28% more cell death than wt
virus, respectively. The rUd-R38A, rUd-123/4 and rUd-103/106
viruses induced cell death at a level comparable to wt virus, as did
the viruses unable to activate PI3K, rUd-Y89F and rUd-P164/7A.
Previous reports have suggested that the activation of PI3K by
inﬂuenza virus is required for cell survival (Ehrhardt et al., 2007;
Shin et al., 2007a; Zhirnov and Klenk, 2007); however, the data
reported here suggest that the loss of PI3K activation during virus
infection has no effect on cell viability.To determine whether cell death was apoptotic, the A549 cell
lysates from Fig. 2b were subjected to SDS-PAGE and immunoblotting.
Activated caspase-3 and cleaved poly (ADP-ribose) polymerase
(cPARP; a downstream caspase target) were detected as markers of
apoptosis (Fig. 3b). High levels of both activated caspase-3 and cPARP
were found in cells infected with rUd-184-8(P) and rUd-Δ99 viruses,
but absent in those infected with rUd wt, rUd-Y89F or rUd-P164/7A
viruses. Intermediate levels of both proteins were detected in cells
infected with the rUd-P162/4/7A and rUd-184-8(L) viruses, with
only low levels of each found in cells infected with the remaining
mutant viruses.
rUd-P162/4/7A, rUd-Δ99, rUd-184-8(P) and rUd-184-8(L)
viruses, all of which induced apoptosis as determined by the presence
of cPARP and activated caspase-3 (Fig. 3b), did not activate Akt at 24 h
p.i. (Fig. 2b). However, pAkt was also undetectable in cells infected
with the rUd-Y89F or rUd-P164/7A viruses (Fig. 2b), neither of which
resulted in caspase activation (Fig. 3b). Therefore, there appeared to
be no correlation between the induction of apoptosis and inﬂuenza
virus-induced activation of PI3K.
The results in Fig. 3b show that the rUd-Y89F virus did not activate
caspase-3, the rUd-P162/4/7A virus induced intermediate levels of
caspase activation and the rUd-184-8(P) virus induced high levels of
caspase activation. A more accurate determination of caspase
activation by these viruses was performed using a quantitative
Caspase-Glo assay in which the level of luminescence is a direct
measurement of the extent of caspase activation. A549 cells were
infected with a selection of mutant viruses and at 24 h p.i. cells were
lysed and luminescencewasmeasured (Fig. 3c). Results correlate with
those in Fig. 3b in that the rUd-Y89F virus did not inducemore caspase
activation than rUd wt virus, the rUd-184-8(P) virus induced high
levels of caspase activation and that of the rUd-P162/4/7/A virus was
intermediate with respect to the other viruses.
Apoptosis induction leads to chromatin condensation and nuclear
fragmentation, which can be determined by staining the DNA with
4′,6-diamidino-2-phenylindole (DAPI). A549 cells were infected with
the rUd wt, rUd-Y89F, rUd-P162/4/7A, and rUd-184-8(P) viruses at
an MOI of 5 for 24 h, after which they were ﬁxed and permeabilised.
Infected cells were detected by the staining of viral antigen using a
rabbit anti-X31 antibody and the nuclear structure was visualised by
staining with DAPI (Fig. 3d). The only virus that induced apoptosis-
mediated nuclear fragmentation was that which induced high levels
of cPARP and caspase activation, the rUd-184-8(P) virus.
Overall, the results in Figs. 3a–d demonstrate that a number of
mutant viruses induced more cell death than wt virus and that the
levels of cell death for each mutant virus correlated with levels of
apoptosis induction. Markers of apoptosis were undetectable in rUd
wt and rUd-Y89F virus-infected A549 cells. Therefore, it can be
concluded that the NS1 protein of wt inﬂuenza virus, through its
inherent functions, is able to limit the induction of apoptosis during
virus infection. However, the NS1-mediated effects on apoptosis in
virus-infected cells are independent of PI3K activation.
The activation of PI3K does not prevent inﬂuenza virus-induced
apoptosis in rUd-184-8(P) virus-infected cells
Neither the rUd-Y89F nor rUd-184-8(P) viruses activate PI3K, but
both viruses differ signiﬁcantly in their ability to induce apoptosis.
Since it is well-known that fetal calf serum (FCS) activates PI3K, the
effects of FCS-mediated PI3K activation on cell survival were assessed
in cells infected with these mutant viruses. A549 cells were infected
with rUd wt, rUd-Y89F or rUd184-8(P) virus at an MOI of 5 in the
presence or absence of 10% FCS. At 36 h p.i., the level of cell viability of
rUd wt and rUd-Y89F virus-infected cells was slightly reduced when
compared to uninfected cells; however, the addition of FCS did not
alter the viability of cells infected with these viruses (Fig. 4a).
Although the addition of FCS slightly increased the viability of rUd-
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than those of rUd wt virus-infected cells. In addition, cells infected in
the presence or absence of FCS were analysed for the presence of
cPARP. A549 cells were infected with rUd wt, rUd-Y89F or rUd184-8
(P) virus at an MOI of 5 in the presence or absence of 10% FCS and at
24 h p.i. cells were lysed and analysed by SDS-PAGE. The inﬂuenza A
virus M1 protein was detected to ensure cells were equally infected
with all viruses. The expression level of the different NS1 proteins was
also determined. As was shown in Figs. 2a and b, cells infected with
the rUd-184-8(P) virus demonstrated only slightly reduced levels of
M1 but signiﬁcantly reduced levels of NS1 compared to rUd wt virus-
infected cells (Fig. 4b). The FCS-mediated activation of PI3K was
detected by the presence of pAkt in cells infected with all viruses;
however, the only virus that induced PI3K activation in the absence of
FCS was rUd wt virus. cPARP was only detectable following infection
with the rUd-184-8(P) virus, and this occurred in both the presence
and absence of FCS. These results demonstrate that apoptosis
induction by mutant inﬂuenza viruses is independent of, and cannot
be overcome by, the activation of PI3K.
Characterisation of mutant virus-induced cell death in MRC-5 cells
It is possible that the effects of the mutant NS1 proteins on cell
viability and apoptosis induction (Fig. 3) are cell type-dependent.
Since A549 cells are carcinoma-derived, they may exhibit defects in
their apoptotic pathways, affecting their response to these NS1
mutant viruses. It was therefore desirable to determine whether PI3K
activation is required to prevent inﬂuenza virus-induced cell death in
an untransformed cell-line. MRC-5 cells are untransformed human
fetal lung ﬁbroblasts that undergo senescence following continued
passage and are thus likely to have intact intracellular responses to
virus infection, including those which lead to the induction of
apoptosis. Furthermore, they are permissive to inﬂuenza virus
infection (de Ona et al., 1995; Herrero-Uribe et al., 1983). To
determine whether MRC-5 cells were more sensitive to apoptosis
than A549 cells, their sensitivity to Fas ligand (FasL)-induced (Fig. 5a)
and staurosporine-induced (Fig. 5b) cell death was compared to that
of A549 and Hep2 cells, an additional, widely used carcinoma cell-line.
Both A549 and Hep2 cells were resistant to FasL and Hep2 cells were
only slightly more susceptible to staurosporine-induced cell death
than A549 cells. However, of relevance to data presented below, it
should be noted that A549 cells are sensitive to FasL in the presence of
cycloheximide (data not shown). In contrast, MRC-5 cells were highly
sensitive to both FasL- and staurosporine-induced cell death, with
only 20% of cells remaining viable at 6 h post-treatment (p.t.). Similar
results were obtained in cells treated with TNF-α/cycloheximide
(data not shown). Therefore, of the three cell-lines tested, MRC-5 cells
are the most sensitive to both intrinsic and extrinsic inducers of
apoptosis.
MRC-5 cells were infected with the panel of mutant viruses and
the extent of cell death was quantiﬁed at various times p.i. The results
of a selection of viruses are shown in Fig. 5c. It is interesting to note
that even thoughMRC-5 cells are sensitive to FasL- and staurosporine-
induced cell death by 6 h p.t., the vast majority remained viable for
over 48 h after a high MOI infection with wt inﬂuenza virus. Overall,
the results with the mutant viruses were similar to those obtained inFig. 3. Cell viability and the induction of apoptosis in mutant virus-infected cells. (a) A549
measured by wst-1 assay at 12, 24, 30 and 36 h p.i. The horizontal line represents the perce
percentage viability of uninfected cells at each time point and represent the average of tripl
from Fig. 2 were separated by SDS-PAGE and immunoblotted for cleaved or uncleaved poly (A
(c) A549 cells were infected with rUd wt, rUd-Y89F, rUd-P162/4/7A or rUd-184-8(P) virus
measured using the Caspase-Glo luminescence assay. Results represent the average of triplic
cells were infected with rUdwt, rUd-Y89F, rUd-P162/4/7A or rUd-184-8(P) virus at anMOI o
were determined by staining viral antigens (shown in green) using a rabbit anti-X31 prima
infected cells was determined by staining the DNA with DAPI (shown in blue). In rUd-184-
cells.A549 cells: the rUd-184-8(P) virus induced the most cell death with
the rUd-P162/4/7A virus inducing slightly more (17%) than the wt
virus. However, even with the rUd-184-8(P) virus, roughly 50% of
cells were still viable at 24 h p.i. The two viruses unable to activate
PI3K, rUd-Y89F and rUd-P164/7A, caused similar levels of cell death
to wt virus. Therefore, as in A549 cells, abrogation of NS1-mediated
PI3K activation did not induce cell death in MRC-5 cells.
Neither PI3K activation by NS1 nor infection of cells with inﬂuenza A
virus protects them from non-viral inducers of apoptosis
Although PI3K activation by NS1 did not affect the levels of virus-
induced apoptosis, it may act to limit death of infected cells by
inducers of apoptosis produced in the context of an immune response.
To investigate this, an A549 cell-line constitutively expressing V5-
tagged NS1 (A549-PR8/NS1 cells) was generated. NS1 expressionwas
readily detectable by immunoblottingwith an anti-V5 antibody and in
addition, Akt was activated in these cells in the absence of FCS
treatment (Fig. 6a). Both A549 and A549-PR8/NS1 cells were treated
with FasL in conjunction with cycloheximide (FasL/CHX; note A549
cells are resistant to FasL alone, Fig. 5a), or staurosporine, and cell
viability was quantiﬁed at several times post-treatment by wst-1
assay. Both cell-lines demonstrated a reduction in cell viability at
similar rates following treatment with both FasL/CHX (Fig. 6b) and
staurosporine (Fig. 6c) and also TNF-α/CHX (data not shown). These
data indicate that NS1 may be unable to act as a direct inhibitor of
either extrinsic or intrinsic apoptotic pathways in A549 cells.
To investigate whether virus infection could inhibit induction
of apoptosis, MRC-5 and A549 cells were infected with rUd wt or
rUd-Y89F virus for 12 and 14 h, respectively, and subsequently
treated with FasL. Cell viability was then measured by wst-1 assay at
various times p.i. MRC-5 cells infected with rUd wt virus went into
FasL-induced apoptosis more rapidly than uninfected cells (Fig. 7a).
A549 cells, which are resistant to FasL treatment (Fig. 5a), became
sensitive to FasL during infection with rUd wt virus, with the majority
of cells dyingwithin 6 h of treatment (Fig. 7b). This sensitisation effect
is likely to be due to virus-induced shut-off of host protein synthesis
inhibiting the production of host anti-apoptotic factors. Furthermore,
for both MRC-5 and A549 cells, both rUd wt and rUd-Y89F virus-
infected cells went into apoptosis at the same rate, again indicating
that PI3K activation by NS1 does not prevent FasL-mediated
apoptosis. Both rUd wt and rUd-Y89F virus-infected MRC-5 and
A549 cells also exhibited similar viability curves following staur-
osporine treatment (data not shown). These data demonstrate that
neither inﬂuenza A virus infection, nor the activation of PI3K by NS1,
can prevent apoptosis induction by non-viral stimuli in inﬂuenza
virus-infected cells.
Discussion
As the activation of PI3K by NS1 has been suggested to limit
apoptosis induction in inﬂuenza virus-infected cells (Ehrhardt et al.,
2007; Shin et al., 2007a; Zhirnov and Klenk, 2007), three mutants
(rUd-Y89F, rUd-P164/7A and rUd-P162/4/7A viruses) were designed
speciﬁcally to further examine the role of PI3K and apoptosis in virus
infection. Although pAkt was undetectable in rUd-Y89F virus-infectedcells were infected with the panel of mutant viruses at an MOI of 35. Cell viability was
ntage cell viability of rUd wt virus at 36 h p.i. Results for each virus are expressed as a
icate experiments (±S.D.). (b) Proteins in the 24 h p.i. virus-infected A549 cell lysates
DP-ribose) polymerase (cPARP;PARP) and activated caspase-3 as markers of apoptosis.
at an MOI of 35. At 24 h p.i., cells were lysed and virus-induced caspase activation was
ate experiments (±S.D.). (d) Immunoﬂuorescence analysis of virus-infected cells. A549
f 5 and at 24 h p.i. cells were ﬁxed in 5% formalin and permeabilised. Virus-infected cells
ry antibody and a FITC-conjugated secondary antibody. The nuclear structure of virus-
8(P) virus-infected cells, the white arrows indicate the fragmented nuclei of apoptotic
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activated), some pAkt was seen in rUd-P164/7A virus-infected cells at
12 h, but not 24 h p.i. To activate PI3K, the effector domain of NS1
interacts with the iSH2 domain of the p85β regulatory domain in a
way that relieves the inhibitory action of p85β on the p110 catalytic
subunit (Hale et al., 2008a). We have recently solved the structure of
the effector domain of NS1 with β-iSH2 (Hale et al., 2009). Whilst it is
unlikely that P167 contributes to β-iSH2 binding, residues Y89 and
P164 bury more than 90 Å2 of surface area upon binding β-iSH2 (Hale
et al., 2009) and are therefore the two residues of NS1 that contribute
most to the interfacial surface area (Fig. 8). However, Y89 is
positioned at the heart of the complex, whilst P164 lies at the
extreme edge. It is thus possible that the P164A mutation may
signiﬁcantly weaken, but not completely prevent, the NS1–iSH2
interaction, which could explain the slight activation of PI3K observed
in rUd-P164/7A virus-infected cells early in infection (Fig. 2a).
However, in combination with the P162A mutation, it is likely that
this entire region of NS1 would be disrupted, thereby explaining the
failure of rUd-P162/4/7A virus to activate PI3K (Fig. 2a).
When analysing the effects of both rUd-Y89F and rUd-P164/7A
viruses on apoptosis induction, it became apparent that neither virus
induced more apoptosis than wt virus in A549 or MRC-5 cells, evenFig. 4. The effects of serum-mediated activation of PI3K on the viability of mutant
virus-infected cells. (a) A549 cells were infected with rUd wt, rUd-Y89F or rUd-184-8
(P) virus at an MOI of 35. After virus adsorption for 1 h, cells were incubated in either
serum-free DMEM or DMEM supplemented with 10% FCS. Cells were lysed at 36 h p.i.
and viability was measured by wst-1 assay. Results of virus-infected cells are plotted
relative to uninfected cells. Results represent the average of triplicate experiments
(±S.D.). (b) A549 cells were infected with rUd wt, rUd-Y89F or rUd-184-8(P) virus at
an MOI of 5. After the initial period of virus adsorption, cells were incubated in either
serum-free DMEM or DMEM supplemented with 10% FCS for 24 h followed by lysis in
disruption buffer. Proteins were separated by SDS-PAGE followed by immunoblotting
for PARP/cPARP, pAkt, M1, NS1 and β-actin.
Fig. 5. The sensitivity of various cell-lines to apoptosis inducers. A549, MRC-5 or Hep2
cells were treated with (a) FasL or (b) staurosporine and cell viability was measured by
wst-1 assay at 6, 12, 24, 36 and 48 h post-treatment. (c) MRC-5 cells were infected with
rUdwt, rUd-Y89F, rUd-P164/7A, rUd-P162/4/7A or rUd-184-8(P) virus at an MOI of 35
and cell viability was measured by wst-1 assay at 18, 36 and 48 h p.i. Results represent
the average of triplicate experiments (±S.D).though these cells are particularly sensitive to intrinsic and extrinsic
inducers of apoptosis. Indeed, it was striking how little cell death was
induced by infection of these cells with the rUdwt, rUd-Y89F and rUd-
P164/7A viruses. Thus, approximately 80% of MRC-5 cells were still
Fig. 6. Constitutive expression of NS1 does not inhibit apoptosis in A549 cells. A549 or
A549-PR8/NS1 cells were incubated in the presence or absence of 10% FCS for 12 h, then
lysed in disruption buffer. Proteins were separated by SDS-PAGE and immunoblotted
for the presence of pAkt, V5 and β-actin (a). A549 and A549-PR8/NS1 cells were serum-
starved then treated with FasL/CHX (b) or staurosporine (c) in the absence of FCS. Cell
viability was measured at several times post-treatment by wst-1 assay. Results
represent the average of triplicate experiments (±S.D).
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treatment with FasL or staurosporine (MRC-5 cells are untransformed
and are thus unlikely to have any deﬁciencies in their apoptosis
inducing pathways). Although the rUd-184-8(P) virus induces more
cell death than rUd wt and does not activate PI3K/Akt (Fig. 2), it is
likely that loss of other NS1 functions (perhaps due to the mutations
changing the overall structure of its effector domain) or a reduction in
the level of NS1 translation is the reason for this. This conclusion is
supported by the observation that serum-mediated activation of PI3K
in rUd-184-8(P) virus-infected cells was unable to prevent the cells
from undergoing apoptosis (Fig. 4). Similarly, the rUd-Δ99 virus,
which induces more cell death than wt virus and fails to activate PI3K,
lacksmost of the C-terminal effector domain andwill therefore also be
deﬁcient in a number of NS1 functions. These results therefore suggest
that it is a general loss of NS1 function, rather than an inability to
activate PI3K, which leads to the induction of apoptosis.
Our results are in conﬂict with three previous reports which have
suggested that PI3K activation is required to block apoptosis in
inﬂuenza virus-infected MDCK cells (Ehrhardt et al., 2007; Shin et al.,
2007a; Zhirnov and Klenk, 2007). A recent report has also suggested
that PI3K activation may prolong the survival of chickenmacrophages
infected with avian inﬂuenza virus (Xing et al., 2009). Further work is
therefore required to determine whether the effects of PI3K activation
and apoptosis differ between cell types, and whether the strain or
subtype of inﬂuenza virus inﬂuences these effects. However, in our
hands rUd-Y89F does not cause more apoptosis in MDCK cells than
rUd wt virus (data not shown). Thus, the reasons for difference in the
data presented here and previously may relate to the use of a virus
lacking NS1 coding capacity (delNS1), which will be deﬁcient in all
NS1 functions, (Zhirnov and Klenk, 2007) or the PI3K pharmacological
inhibitor LY294002 (Ehrhardt et al., 2007; Zhirnov and Klenk, 2007).
LY294002 is widely regarded as a promiscuous inhibitor and affects
the activity of a signiﬁcant number of other kinases, including the
PI3K downstream targets mTOR and GSK3, at the concentrations
required for PI3K inhibition (Bain et al., 2007; Davies et al., 2000;
Gharbi et al., 2007). LY294002 treatment has also been shown to
inhibit NF-kB activity, cytokine induction and cell proliferation
independently of PI3K inhibition, and its use has led to misleading
results in innate immunity studies (Hazeki et al., 2006; Kim et al.,
2005; Kristof et al., 2005). Moreover, one study has expressly
recommended that LY294002 no longer be used in PI3K cell-based
assays (Bain et al., 2007).
With regard to the relevance of the other functions of NS1 and
apoptosis, the introduction of the R38A and I123A/M124A muta-
tions into NS1, which abrogates inhibitory effects on OAS/RNase L
and PKR, respectively, had minimal effects on the induction of
apoptosis (Fig. 3b). This was surprising as activation of PKR and
OAS/RNase L have been implicated in triggering apoptosis during
virus infection (Castelli et al., 1997; Takizawa, Ohashi, and
Nakanishi, 1996). The rUd-103/106 virus, which has mutations in
NS1 that destabilizes the interaction with CPSF30 (Twu et al., 2007),
did not induce more cell death than wt virus, which may be due to
the cognate viral polymerase forming a functional polymerase:NS1:
CPSF30 complex (Kuo and Krug, 2009). However, rUd-184-8(L)
virus, which does not interact with CPSF30 (Noah, Twu, and Krug,
2003), induced more cell death and increased PARP cleavage
compared to wt virus late in infection. Therefore, a failure of NS1
to interact with CPSF30 appears to promote apoptosis. Although the
NS1:CPSF30 interaction is thought to limit IFN production, it appears
that the induction of apoptosis by the mutant viruses in this study is
not a direct result of IFN production. The rUd-184-8(P) and rUd-Δ99
viruses, which induced the highest levels of apoptosis and in which
NS1 cannot interact with CPSF30, induced more IFN than wt virus
(data not shown). However, in IFN-β-deﬁcient Vero cells and
A549-NPro cells that are IRF3-deﬁcient due to constitutive expres-
sion of NPro from bovine viral diarrhea virus (Hilton et al., 2006),the rUd-184-8(P) and rUd-Δ99 viruses caused similar levels of
apoptosis to those observed in naïve A549 cells. This indicates that
apoptosis induction is not a direct result of IFN production but that
there may be a common inducer of IFN and apoptosis in virus-
infected cells (unpublished observations).
Although the activation of PI3K by NS1 does not affect the levels of
virus-induced apoptosis (at least in human lung epithelial and
Fig. 7. NS1-mediated PI3K activation does not prevent FasL-induced apoptosis in virus-
infected cells. (a) MRC-5 cells or (b) A549 cells were infected with rUd wt or rUd-Y89F
virus at an MOI of 35. Cells were treated with FasL at 12 h p.i. (A549 cells) or 14 h p.i.
(MRC-5 cells). Cell viability was measured by wst-1 assay at several times p.i. Results
represent the average of triplicate experiments (±S.D.).
Fig. 8. Structural analysis of the NS1–iSH2 interaction. (a) Cartoon representation of the
NS1–iSH2 interface, highlighting the relative positions of NS1 residues involved in
binding the β-iSH2 domain of p85β. (b) Cartoon representation of the NS1 effector
domain complexed with β-iSH2, highlighting the relative positions of the NS1 residues
involved in β-iSH2 and CPSF30 binding.
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induction of extrinsic inducers of apoptosis produced during an
immune response to viral infection. However, in this study, activation
of PI3K by constitutive expression of NS1 did not protect A549 cells
from non-viral apoptosis inducers. Moreover, rUd wt virus-infected
cells remained sensitive to cell death with inducers of apoptosis,
suggesting that inﬂuenza A viruses do not directly block the induction
of apoptosis. The results presented here therefore strongly suggest
that PI3K activation by NS1 is not related to a requirement of the virus
to block apoptosis. Consequently, the question remains as to why NS1activates PI3K. Given the myriad of cellular activities that are affected
by PI3K activation this is not going to be easy to answer. However,
rUd-Y89F virus is attenuated in MDCK (Hale et al., 2006), MRC-5 and
A549 cells (data not shown), indicating that PI3K activation is
required for efﬁcient virus replication for reasons which remain
unknown. It has also recently been reported that activation of PI3K by
NS1 inﬂuences cation currents in human airway epithelial cells
(Gallacher et al., 2009), and this may play a role in virus pathogenesis.
Whilst further work needs to be carried out with regard to the
importance of this latter observation, nevertheless it highlights the
importance of continuing to study the biological signiﬁcance of PI3K
activation by NS1.
Materials and methods
Cells and viruses
293-T, A549, Hep2, MRC-5 and Madin-Darby canine kidney
(MDCK) cells were maintained in Dulbecco's modiﬁed Eagle's
medium (DMEM) (Invitrogen) supplemented with 10% fetal calf
serum (FCS) in a humidiﬁed incubator at 37 °C with 5% CO2. MDCK
cells stably expressing the V protein of PIV5 (MDCK-V cells) were
generated previously (Andrejeva et al., 2002) by transfection with a
pEF.SV5-V plasmid using Lipofectamine transfection reagent (Invitro-
gen) and selected/maintained in the presence of 200 μg/mL G418
(Geneticin; Invitrogen). A549 cells stably expressing the NS1 protein
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lentivirus expression system, as described previously (Hale et al.,
2006).
A/Udorn/72 wild-type (rUd wt) and mutant viruses were
generated by plasmid-based reverse genetics essentially as previously
described (Fodor et al., 1999; Neumann et al., 1999). Brieﬂy, 293-T
cells were transfected with eight genome-sense (pHH21) plasmids
(0.5 μg of each) and four protein expression plasmids (pcDNA3.1)
encoding PB1, PB2, PA and NP (1 μg of each) using FuGENE 6
transfection reagent (Roche). Sixteen hours post-transfection, 293-T
cells were resuspended in DMEM containing 10% FCS and co-cultured
withMDCK-V cells. Eight hours later, the overlaymedia were replaced
with serum-free DMEM containing 2.5 μg/mL N-acetyl trypsin
(Sigma). Viruses were propagated through two passages in MDCK-V
cells overlaid with serum-free DMEM containing 2.5 μg/mL N-acetyl
trypsin at 37 °C followed by plaque assay titration on MDCK-V cells.
Viral RNA was extracted using the QIAamp viral RNA kit (QIAGEN),
followed by reverse-transcriptase PCR using genome-speciﬁc primers
and the resultant DNA sequenced to conﬁrm the presence of the
introduced mutations. All inﬂuenza virus infections were performed
in serum-free DMEM unless otherwise stated.
Plasmids and transfections
Mutant viruses were generated by substituting the pHH-NS
“rescue” plasmid for mutated versions in the rescue transfection.
These plasmids (pHH-NS1-Y89F, pHH-NS1-P164/7A, pHH-NS1-
P162/4/7A, pHH-NS1-R38A, pHH-NS1-123/4, pHH-NS1-184-8,
pHH-NS1-103/106) were generated by site-directed mutagenesis of
pHH-NS using the QuikChange mutagenesis kit (Stratagene) and
speciﬁc primers (primer sequences available on request). The
sequence of the mutated plasmids was conﬁrmed by DNA sequencing
and plasmids were used in the reverse genetics system as described
above.
Antibodies
Goat serum raised to puriﬁed and disrupted A/Udorn/72 virus
(goat anti-Udorn; kindly provided by Robert Lamb, Northwestern
University, USA) was used to detect the inﬂuenza A virus M1 protein
by immunoblotting. The NS1 protein was detected by immunoblot-
ting using puriﬁed antisera (produced by Diagnostics Scotland) raised
against the NS1 protein of the A/Puerto Rico/8/34 (PR8) strain. PARP/
cleaved PARP (cPARP), activated caspase 3, phosphorylated Akt
(pAkt), V5 and β-actin were detected by immunoblotting using
anti-PARP (Roche), anti-phospho-Akt(Ser 473) (Cell Signaling Tech-
nology), anti-cleaved caspase-3(Asp 175) anti-V5 (Serotec) and anti-
β-actin (Sigma-Aldrich) antibodies, respectively. Viral antigen detec-
tion for the immunostaining of plaques was performed using sheep
antisera raised against puriﬁed and disrupted X31 virus (sheep anti-
X31; produced by Diagnostics Scotland). Viral antigen detection by
immunoﬂuorescence was performed using rabbit antisera raised
against puriﬁed and disrupted X31 virus (rabbit anti-X31; kindly
provided by A. Douglas, National Institute for Medical Research,
London).
Immunoblotting
Infected cells were lysed in 2× disruption buffer (6M Urea/2M
β-mercaptoethanol/4% sodium dodecyl sulphate) and nucleic acids
disrupted by sonication. Samples were boiled for 5 min, and poly-
peptides were separated on a NuPAGE 4–12% Bis-Tris gel (Invitrogen)
by SDS-PAGE and transferred to polyvinylidene diﬂuoride (PVDF)
membranes (Invitrogen). Membranes were placed in blocking buffer
(PBS/0.1% Tween 20/5% dried milk) for 1 h at room temperature.
Membranes were then incubated with the appropriate primaryantibody in blocking buffer at 4 °C overnight. For detection of pAkt,
membranes were incubated in blocking buffer containing a horserad-
ish peroxidase conjugated secondary antibody for 1 h at room
temperature followedby the addition of ECL substrate (GEHealthcare)
and detection on autoradiography ﬁlm. For detection of all other
proteins, membranes were incubated in blocking buffer containing an
alkaline phosphatase-conjugated secondary antibody for 1 h at room
temperature followed by detection with SIGMA FAST BCIP/NBT
substrate (Sigma-Aldrich).
Plaque assays
MDCK cells in 6-well plates were infected with serial tenfold
dilutions of each virus in serum-free DMEM for 1 h at 37 °C. Cells were
washed in PBS, overlaid with DMEM-1% agarose supplemented with
2 μg/mL N-acetyl trypsin and incubated at 37 °C for 48 h. Cells were
ﬁxed in formalin for 1 h at room temperature, washed in PBS and
blocked in PBS/1% BSA/0.02% Na azide (PBN). Plaques were visualised
by immunostaining by incubating the cells with the sheep anti-X31
primary antibody diluted in PBN followed by an alkaline phosphatase-
conjugated donkey anti-goat secondary antibody (Santa Cruz) diluted
in PBN for 1 h each at room temperature. Plaques were visualised
using the SIGMA FAST BCIP/NBT substrate.
Wst-1 cell viability assay
A549, Hep2 or MRC-5 cells in 96-well plates were either infected
with virus or treated with 1 μg/mL staurosporine (Sigma) or
200 ng/mL FasL in conjunction with FasL enhancer (Alexis Biochem-
icals) followed by incubation at 37 °C. Immunoﬂuorescence-based
virus titration studies indicated that the infection efﬁciency of cells in
96-well plates was considerably lower than larger culture dishes and
that amultiplicity of infection (MOI) of 35was required to infect every
cell. At desired times post-infection/-treatment, wst-1 reagent
(Roche) was added to each well according to the manufacturer's
instructions and plates were brieﬂy shaken to mix culture medium
and reagent. Plates were incubated at 37 °C until signiﬁcant color had
developed in the wells containing untreated/uninfected cells. Plates
were then read at 450 nmon an ELISAmicroplate reader using 690 nm
as a reference wavelength. Percentage cell viability for each condition
was calculated relative to uninfected and/or untreated cells. Results
represent the average of triplicate experiments (±S.D.).
Luciferase-based caspase activation assay
A549 cells in white-walled 96-well plates were infected with a
selection of mutant viruses at an MOI of 35 for 24 h. To measure the
activation of caspases-3 and -7, cells were lysed by the addition of the
Caspase-Glo 3/7 Reagent (Promega), which also contains a caspase3/
7 substrate, according to the manufacturer's instructions. Plates were
brieﬂy shaken and incubated for 1 h at room temperature. The
luminescent signal generated by caspase cleavage of the substrate is
proportional to caspase activity in the sample. Luminescence was
read on a 96-well microplate reader. Blank (medium only) wells
were included on each plate and readings were subtracted from
experimental values. Results represent the average of triplicate
experiments (±S.D.).
Immunoﬂuorescence
At 18 h post-infection, virus-infected A549 cells on glass coverslips
were ﬁxed in formalin for 15 min followed by permeabilisation in
PBS/1% Triton X-100/1% NP40 permeabilisation buffer for 10 min.
Cells were blocked in PBN for 1 h at room temperature followed by
incubation with the rabbit anti-X31 primary antibody diluted in PBN
for 1 h at room temperature. Cells were then incubated with a FITC-
104 D. Jackson et al. / Virology 396 (2010) 94–105conjugated goat anti-rabbit secondary antibody (Oxford Biotechno-
logy) for 1 h at room temperature. Cells were incubated with DAPI for
5 min at room temperature and coverslips were mounted on glass
slides using Vectashield mounting media (Vector Laboratories).
Images were captured using a Deltavision RT deconvolution micros-
cope (Applied Precision).
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